|
1
|
Tang L, Mao Y, Liu L, et al: The volume to
be irradiated during selective neck irradiation in nasopharyngeal
carcinoma: analysis of the spread patterns in lymph nodes by
magnetic resonance imaging. Cancer. 115:680–688. 2009.
|
|
2
|
Agulnik M and Siu LL: State-of-the-art
management of nasopharyngeal carcinoma: current and future
directions. Br J Cancer. 92:799–806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caponigro F, Longo F, Ionna F and Perri F:
Treatment approaches to nasopharyngeal carcinoma: a review.
Anticancer Drugs. 21:471–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brodeur GM, Minturn JE, Ho R, et al: Trk
receptor expression and inhibition in neuroblastomas. Clin Cancer
Res. 15:3244–3250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schramm A, Schulte JH, Astrahantseff K, et
al: Biological effects of TrkA and TrkB receptor signaling in
neuroblastoma. Cancer Lett. 228:143–153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ricci A, Greco S, Mariotta S, et al:
Neurotrophins and neurotrophin receptors in human lung cancer. Am J
Respir Cell Mol Biol. 25:439–446. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sclabas GM, Fujioka S, Schmidt C, et al:
Overexpression of tropomysin-related kinase B in metastatic human
pancreatic cancer cells. Clin Cancer Res. 11:440–449.
2005.PubMed/NCBI
|
|
9
|
Zhang Y, Fujiwara Y, Doki Y, et al:
Overexpression of tyrosine kinase B protein as a predictor for
distant metastases and prognosis in gastric carcinoma. Oncology.
75:17–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu X, Liu L, Cai B, He Y and Wan X:
Suppression of anoikis by the neurotrophic receptor TrkB in human
ovarian cancer. Cancer Sci. 99:543–552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu Y, Zhang S, Wang X, Yang Z and Ou G:
Overexpression of TrkB promotes the progression of colon cancer.
APMIS. 118:188–195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao KT, Zhang HY, Zhu HC, et al:
Establishment and characterization of two epithelial tumor cell
lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus
and derived from nasopharyngeal carcinomas. Int J Cancer. 45:83–89.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheung ST, Huang DP, Hui AB, et al:
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring
Epstein-Barr virus. Int J Cancer. 83:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Fan Y, Chen J, Yao KT and Huang ZX:
Microarray analysis of differentially expressed genes between
nasopharyngeal carcinoma cell lines 5–8F and 6–10B. Cancer Genet
Cytogenet. 196:23–30. 2010.
|
|
15
|
Tsao SW, Wang X, Liu Y, et al:
Establishment of two immortalized nasopharyngeal epithelial cell
lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim
Biophys Acta. 1590:150–158. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan AT, Teo PM, Ngan RK, et al:
Concurrent chemotherapy-radiotherapy compared with radiotherapy
alone in locoregionally advanced nasopharyngeal carcinoma:
progression-free survival analysis of a phase III randomized trial.
J Clin Oncol. 20:2038–2044. 2002. View Article : Google Scholar
|
|
17
|
Xu T, Hu C, Wang X and Shen C: Role of
chemoradiotherapy in intermediate prognosis nasopharyngeal
carcinoma. Oral Oncol. 47:408–413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen MK, Yang SF, Lai JC, et al:
Expression of bcl-2 correlates with poor prognosis and modulates
migration of nasopharyngeal carcinoma cells. Clin Chim Acta.
411:400–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Casaletto JB and McClatchey AI: Spatial
regulation of receptor tyrosine kinases in development and cancer.
Nat Rev Cancer. 411:387–400. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimizu M, Adachi S, Masuda M, Kozawa O
and Moriwaki H: Cancer chemoprevention with green tea catechins by
targeting receptor tyrosine kinases. Mol Nutr Food Res. 55:832–843.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edsjö A, Lavenius E, Nilsson H, et al:
Expression of TrkB in human neuroblastoma in relation to MYCN
expression and retinoic acid treatment. Lab Invest. 83:813–823.
2003.PubMed/NCBI
|
|
22
|
Eggert A, Ikegaki N, Liu XG and Brodeur
GM: Prognostic and biological role of neurotrophin-receptor TrkA
and TrkB in neuroblastoma. Klin Padiatr. 212:200–205. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miknyoczki SJ, Lang D, Huang L,
Klein-Szanto AJ, Dionne CA and Ruggeri BA: Neurotrophins and Trk
receptors in human pancreatic ductal adenocarcinoma: expression
patterns and effects on in vitro invasive behavior. Int J Cancer.
81:417–427. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Desmet CJ and Peeper DS: The neurotrophic
receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life
Sci. 63:755–759. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Geiger TR and Peeper DS: The neurotrophic
receptor TrkB in anoikis resistance and metastasis: a perspective.
Cancer Res. 65:7033–7036. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kupferman ME, Jiffar T, El-Naggar A, et
al: TrkB induces EMT and has a key role in invasion of head and
neck squamous cell carcinoma. Oncogene. 29:2047–2059. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okamura K, Harada T, Wang S, et al:
Expression of TrkB and BDNF is associated with poor prognosis in
non-small cell lung cancer. Lung Cancer. 78:100–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujikawa H, Tanaka K, Toiyama Y, et al:
High TrkB expression levels are associated with poor prognosis and
EMT induction in colorectal cancer cells. J Gastroenterol.
47:775–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Perez-Pinera P, Hernandez T, García-Suárez
O, et al: The Trk tyrosine kinase inhibitor K252a regulates growth
of lung adenocarcinomas. Mol Cell Biochem. 295:19–26. 2007.
View Article : Google Scholar : PubMed/NCBI
|
